Initiator Pharma A/S (DK0060775872) — research page
SE · se-cm-kg/SSME/DK0060775872 · as of 2026-11-06
Identity and listing
The issuer is Initiator Pharma A/S, listed on First North Sweden under ticker DK0060775872, with ISIN DK0060775872 and LEI 213800DFI4I1A5RVKB59. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Initiator Pharma A/S | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | DK0060775872 | source · 2026-11-06 |
| ISIN | DK0060775872 | source · 2026-11-06 |
| LEI | 213800DFI4I1A5RVKB59 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 19 filings in the twelve months to 2026-11-06, across 15 filing days. The median gap between filing days is 20.5 days. The latest filing is dated 2026-10-28 and is of type Investor News, 9 days before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers. Sector medians are not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 19 | 20.5 | 9 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | Investor News | Investor News | Initiator Pharma completes dosing of the last patient in Phase 2a study of pudafensine in vulvodynia |
| 2026-09-14 | Investor News | Investor News | Initiator Pharma strengthens its management team - appoints Annette Säfholm as COO |
| 2026-08-21 | Half year financial report | Half year financial report | INITIATOR PHARMA: Q2 2026 REPORT |
| 2026-08-19 | Investor News | Investor News | Initiator Pharma secures two European patents for pudafensine |
| 2026-06-23 | Investor News | Investor News | Initiator Pharma attends BIO 2026 in San Diego |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record, its location and any auditor changes are not on the record.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events for this register. The halt flag is listed, not halted.
Orderability
The client category outcome is not determinable because the chapter's orderability section carries no client categories. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
Four research houses are named on the issuer's investor-relations page: DNB Carnegie, Redeye, DNB and Carnegie.
| research house | analyst | source · read date |
|---|---|---|
| DNB Carnegie | issuer page · 2026-11-12 | |
| Redeye | issuer page · 2026-11-12 | |
| DNB | issuer page · 2026-11-12 | |
| Carnegie | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is not sealed for this market. No issuer years are sealed, the market earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/DK0060775872 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/ (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/SSME/DK0060775872 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DK0060775872"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a49da4053db35613.